New Cerba Research and Biokortex Partnership

Published on: 

Cerba Research has announced a new partnership with Biokortex to leverage patient biological and medical data to support drug developers and CROs with patient identification and recruitment activity.

The benefits of this new partnership include patients’ biological and medical data from over 25 million patients per year from over 1,000 sites located in Europe, Africa, and North America, a platform for screening and companion diagnostic testing across Europe and Africa, and more.


Click here for more information.